Published

The Potential of Psychedelics for the Treatment of Episodic Migraine.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Current pain and headache reports
Date: 2023-09-01
Source: PubMed
DOI: 10.1007/s11916-023-01145-y
PubMed: 37540398

Authors

Schindler EAD

Watch author

Derived topics and classifications

psilocybin Chronic Pain Headache / Migraine Clinical Trial Review Article Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09 Mechanistic Studies of Psilocybin in Headache DisordersClinicalTrials.gov · 2026-07-13 Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study IClinicalTrials.gov · 2023-10-12 Repeat Dosing of Psilocybin in Headache DisordersClinicalTrials.gov · 2024-02-09